Resultados globales: 5 registros encontrados en 0.02 segundos.
Artículos, Encontrados 5 registros
Artículos Encontrados 5 registros  
1.
18 p, 2.0 MB Insights into the light response of skeletonema marinoi : Involvement of ovothiol / Milito, Alfonsina (Centre de Recerca en Agrigenòmica) ; Orefice, Ida (Stazione Zoologica Anton Dohrn. Department of Marine Biotechnology) ; Smerilli, Arianna (Stazione Zoologica Anton Dohrn. Department of Marine Biotechnology) ; Castellano, Immacolata (Stazione Zoologica Anton Dohrn. Department of Biology and Evolution of Marine Organisms) ; Napolitano, Alessandra (University of Naples "Federico II". Department of Chemical Sciences) ; Brunet, Christophe (Stazione Zoologica Anton Dohrn. Department of Marine Biotechnology) ; Palumbo, Anna (Stazione Zoologica Anton Dohrn. Department of Biology and Evolution of Marine Organisms)
Diatoms are one of the most widespread groups of microalgae on Earth. They possess extraordinary metabolic capabilities, including a great ability to adapt to different light conditions. Recently, we have discovered that the diatom Skeletonema marinoi produces the natural antioxidant ovothiol B, until then identified only in clams. [...]
2020 - 10.3390/md18090477
Marine drugs, Vol. 18, Núm. 9 (September 2020) , art. 477  
2.
13 p, 861.9 KB Ixazomib as postinduction maintenance for patients with newly diagnosed multiple myeloma not undergoing autologous stem cell transplantation : The phase III TOURMALINE-MM4 trial / Dimopoulos, M. A. (Hematology and Medical Oncology. Department of Clinical Therapeutics. National and Kapodistrian University of Athens. School of Medicine) ; Špička, I. (First Department of Medicine. Department of Hematology. First Faculty of Medicine. Charles University. General Hospital in Prague) ; Quach, H. (St Vincent's Hospital (Sydney)) ; Oriol, Albert (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Hájek, R. (Department of Hemato-oncology. University Hospital Ostrava. University of Ostrava. Faculty of Medicine) ; Garg, M. (Leicester General Hospital (Leicester, Regne Unit)) ; Beksac, M. (Department of Hematology. Ankara University) ; Bringhen, S. (Division of Hematology. University of Torino. Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino) ; Katodritou, E. (Department of Hematology. Theagenion Cancer Hospital) ; Chng, W. J. (Department of Hematology-Oncology. National University Cancer Institute. National University Health System. Yong Loo Lin School of Medicine. Cancer Science Institute of Singapore. National University of Singapore) ; Leleu, X. (Pôle Régional de Cancérologie. Department of Haematology. Centre Hospitalier Universitaire La Milétrie-Poitiers) ; Iida, S. (Department of Hematology and Oncology. Nagoya City University. Graduate School of Medical Sciences) ; Mateos, M. V. (Hospital Universitario de Salamanca. Centro de Investigación del Cáncer) ; Morgan, G. (Perlmutter Cancer Center. NYU Langone Health) ; Vorog, A. (Millennium Pharmaceuticals. Inc.. Takeda Pharmaceutical Company Limited) ; Labotka, R. (Millennium Pharmaceuticals. Inc.. Takeda Pharmaceutical Company Limited) ; Wang, B. (Millennium Pharmaceuticals. Inc.. Takeda Pharmaceutical Company Limited) ; Palumbo, A. (Millennium Pharmaceuticals. Inc.. Takeda Pharmaceutical Company Limited) ; Lonial, S. (Department of Hematology and Medical Oncology. Winship Cancer Institute of Emory University) ; Universitat Autònoma de Barcelona
2020 - 10.1200/JCO.20.02060
Journal of Clinical Oncology, Vol. 38 Núm. 34 (january 2020) , p. 4030-4041  
3.
16 p, 1.6 MB Enriched Music-supported Therapy for chronic stroke patients : a study protocol of a randomised controlled trial / Grau-Sánchez, Jennifer (Institut d'Investigació Biomèdica de Bellvitge) ; Segura, Emma (Institut d'Investigació Biomèdica de Bellvitge) ; Sanchez-Pinsach, David (Institut d'Investigació en Intel·ligència Artificial (IIIA-CSIC)) ; Raghavan, Preeti (John Hopkins University) ; Münte, Thomas F. (University of Lübeck) ; Palumbo, Anna Marie (Nordoff-Robbins Center for Music Therapy) ; Turry, Alan (Nordoff-Robbins Center for Music Therapy) ; Duarte, Esther (Hospital del Mar (Barcelona, Catalunya)) ; Särkämö, Teppo (University of Helsinki) ; Cerquides Bueno, Jesus (Institut d'Investigació en Intel·ligència Artificial (IIIA-CSIC)) ; Arcos, Josep Lluis (Institut d'Investigació en Intel·ligència Artificial (IIIA-CSIC)) ; Rodríguez-Fornells, Antoni (Universitat de Barcelona. Institut de Neurociències) ; Universitat Autònoma de Barcelona
Residual motor deficits of the upper limb in patients with chronic stroke are common and have a negative impact on autonomy, participation and quality of life. Music-Supported Therapy (MST) is an effective intervention to enhance motor and cognitive function, emotional well-being and quality of life in chronic stroke patients. [...]
2021 - 10.1186/s12883-020-02019-1
BMC Neurology, Vol. 21 (january 2021)  
4.
10 p, 1.3 MB Predicting the artificial immunity induced by RUTI® vaccine against tuberculosis using universal immune system simulator (UISS) / Pennisi, Marzio (University of Catania. Department of Mathematics and Computer Science) ; Russo, Giulia (Department of Drug Sciences. University of Catania) ; Sgroi, Giuseppe (Department of Mathematics and Computer Science. University of Catania) ; Bonaccorso, Angela (Department of Drug Sciences. University of Catania) ; Parasiliti Palumbo, Giuseppe Alessandro (Department of Mathematics and Computer Science. University of Catania) ; Fichera, Epifanio (Etna Biotech S.r.l.) ; Kumar Mitra, Dipendra (All India Institute of Medical Sciences (Nova Delhi, Índia)) ; Walker, Kenneth B. (TuBerculosis Vaccine Initiative (TBVI)) ; Cardona, Pere-Joan (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Amat, Merce (Archivel Farma S.L) ; Viceconti, Marco (Department of Industrial Engineering. Alma Mater Studiorum. University of Bologna) ; Pappalardo, Francesco (Department of Drug Sciences. University of Catania)
Background: Tuberculosis (TB) represents a worldwide cause of mortality (it infects one third of the world's population) affecting mostly developing countries, including India, and recently also developed ones due to the increased mobility of the world population and the evolution of different new bacterial strains capable to provoke multi-drug resistance phenomena. [...]
2019 - 10.1186/s12859-019-3045-5
BMC bioinformatics, Vol. 20 (December 2019) , p. 504  
5.
8 p, 788.7 KB A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS) / Hájek, R. (University Hospital Ostrava) ; Masszi, T. (St László Hospital (Hongria)) ; Petrucci, M. T. (Sapienza Università di Roma) ; Palumbo, A. (Università di Torino) ; Rosiñol, L. (Hospital Clínic i Provincial de Barcelona) ; Nagler, Arnon. (Chaim Sheba Medical Center (Israel)) ; Yong, K. L. (University College London Cancer Institute) ; Oriol, Albert (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Minarik, J. (University Hospital Olomouc (Olomouc, República Txeca)) ; Pour, L. (University Hospital Ostrava) ; Dimopoulos, M. A. (National and Kapodistrian University of Athens) ; Maisnar, V. (Charles University Teaching Hospital, Hradec Králové) ; Rossi, Davide (Amedeo Avogadro University of Eastern Piedmont) ; Kasparu, H. (Hospital Elisabethinen Linz) ; Van Droogenbroeck, J. (AZ Sint-Jan, Brugge, Belgium) ; Yehuda, D. B. (Hadassah Medical Center, Jerusalem, Israel) ; Hardan, I. (Meir Medical Center, Kfar-Saba, Israel) ; Jenner, M. (University Hospital Southampton NHS Foundation Trust (Regne Unit)) ; Calbecka, M. (Nicolaus Copernicus Hospital, Toruń Poland) ; Dávid, M. (University of Pécs, Hungary) ; de la Rubia, J. (Hospital Universitari i Politècnic La Fe de València) ; Drach, J. (Medical University of Vienna) ; Gasztonyi, Z. (Petz Aladár Megyei Oktató Kórház, Vasvári Pál, Hungary) ; Górnik, S. (Zamojski Szpital Niepubliczny, Zamosc, Poland) ; Leleu, X. (Hopital Huriez, CHRU, Lille, France) ; Munder, M. (University Medicine Mainz, Germany) ; Offidani, M. (Clinica di Ematologia Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Italy) ; Zojer, N. (Center for Oncology, Hematology with Outpatient Department and Palliative Care, Wilhelminenspital, Vienna, Austria) ; Rajangam, K. (Onyx Pharmaceuticals, Inc.) ; Chang, Y. L. (Onyx Pharmaceuticals, Inc.) ; San-Miguel, J. F. (Clínica Universidad de Navarra. Centro de Investigación Médica Aplicada) ; Ludwig, H. (Wilhelminen Cancer Research Institute, Vienna, Austria)
This randomized, phase III, open-label, multicenter study compared carfilzomib monotherapy against low-dose corticosteroids and optional cyclophosphamide in relapsed and refractory multiple myeloma (RRMM). [...]
2017 - 10.1038/leu.2016.176
Leukemia, Vol. 31 (2017) , p. 107-114  

Vea también: autores con nombres similares
1 Palumbo, Anna
1 Palumbo, Anna Marie
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.